The Wings for Life foundation has made a significant commitment to ReNetX Bio, a New Haven based biotech startup that is advancing a cutting-edge therapy for chronic spinal cord injury to clinical trial.

“Wings for Life has been an incredible partner,” says ReNetX CEO Erika R. Smith. “They have given us the means to accelerate launch for a full clinical trial that can provide us with the necessary data to advance these first-in-class therapeutics for patients suffering from chronic spinal cord injury.”